ArticleTurkish journal of physical medicine and rehabilitation2025
Cardiorespiratory rehabilitation program induces additional benefits to hypertension patients: Evidence for improvement of the effort capacity.
Article in Turkish journal of physical medicine and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to assess the impact of an eight-week cardiorespiratory rehabilitation program on stabilizing blood pressure values and increasing the patients' exercise capacity by comparing with other rehabilitation programs, such as hydrotherapy recovery, antihypertensive medication, and recommendations for a healthy life. Patients and methods: The prospective interventional pilot study was carried out with 100 patients (64 females, 36 males; mean age: 46±0.3 years; range, 30 to 60 years) diagnosed with hypertension between January 2023 and February 2023. The patients were divided into four homogeneous groups. An eight-week program was implemented. Group A benefited only from recommendations for a healthy lifestyle. Groups B, C, and D, in addition to the recommendations, benefited from pharmaceutical intervention. Additionally, group C participated in a cardiorespiratory rehabilitation program, and group D participated in a hydrotherapeutic program. Blood pressure values and effort capacity, with the six-minute walk test (6MWT), were registered for all the patients of the groups before the programs and after eight weeks of rehabilitation. Results: Intragroup comparison between baseline and final assessments revealed statistically significant differences for systolic blood pressure (SBP) and diastolic blood pressure (DBP) (p=0.002, p<0.0001). Intergroup comparisons between baseline and postintervention revealed a significant increase in group A for DBP and a decrease for 6MWT (p=0.03, p=0.02). Group B registered a statistically significant decrease for SBP and an increase for 6MWT (p=0.3, p=0.007). Both groups C and D had significant improvements for SBP, DBP, and 6MWT (p<0.0001). Group C had better achievements for 6MWT (239.8±97.80 vs. 321.2±86.66). Group D had the best outcome for SBP and DBP (150.2±6.85 vs. 143.9±4.72, 94.24±2.48 vs. 90.60±2.08). Conclusion: Pharmaceutical treatment brings benefit to the patients. Addition of specialized recovery interventions, such as cardiorespiratory or hydrotherapy programs, increases patient's resistance to effort and stabilizes blood pressure values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.